天然产物研究与开发 ›› 2026, Vol. 38 ›› Issue (9): 2046-2058.doi: 10.16333/j.1001-6880.2026.9.018 cstr: 32307.14.1001-6880.2026.9.018

• 数据研究 • 上一篇    下一篇

基于网络药理学和动物实验探讨甘遂-甘草药对治疗恶性腹水的作用机制

何甜甜,唐大轩,刘亚欧,肖  杨,张  莉 ∗   

  1. 四川省中医药科学院,成都610041

  • 出版日期:2026-09-24 发布日期:2026-09-22
  • 基金资助:

    四川省省级科研院所基本科研业务费项目(2023JDKY0027);四川省省级科研院所青年才俊项目(QNCJRS2022-7)

Mechanism of Kansui Radix-Glycyrrhizae Radix et Rhizoma herb pair in treating malignant ascites based on network pharmacology and animal experiment

HE Tian-tian,TANG Da-xuan,LIU Ya-ou,XIAO Yang,ZHANG Li∗   

  1. Sichuan Academy of Chinese Medicine Sciences,Chengdu 610041,China

  • Online:2026-09-24 Published:2026-09-22

摘要:

基于网络药理学和动物实验探究甘遂-甘草(Kansui Radix-Glycyrrhizae Radix et Rhizoma,KR-GRR)药对治疗恶性腹水(malignant ascites,MA)的作用机制。采用TCMSP 数据库筛选药物活性成分与作用靶点,通过网络药理学预测药对治疗MA 的靶点与信号通路,并构建蛋白互作网络,形成“中药-成分-疾病-靶点”的可视化图,GO 和KEGG 分析预测药对治疗MA 的潜在作用机制。其次,通过分子对接验证活性成分与核心靶点的结合能力。最后采用H22 肝癌细胞构建MA 小鼠模型进行验证。网络药理学结果表明,KR-GRR 药对治疗MA 的核心成分有13 个,相关靶点共51 个,核心靶点为丝氨酸/ 苏氨酸蛋白激酶1(serine/ threonine-protein kinase 1,AKT1)、肿瘤坏死因子(tumor necrosis factor,TNF)、白介素6(interleukin-6,IL-6)、肿瘤蛋白53(tumor protein 53,TP53)、IL-1β 和基质金属蛋白酶9(matrix metallopeptidase 9,MMP9)等。KEGG 分析筛选出了141 条信号通路,结合分子对接结果,推测PI3K/ AKT1 / MMP9 信号通路在KR-GRR 药对治疗MA 的过程中发挥关键作用。动物实验结果显示,2. 5 g/ kg KR-GRR 药对能明显改善 MA 小鼠一般状态、死亡情况和腹膜组织病理损伤,减小腹围和腹水量,抑制腹水中AKT1 和MMP9 的表达,抑制腹膜组织AKT1、TNF、IL-6、TP53、IL-1β、MMP9 mRNA 和p-PI3K、PI3K、p-AKT1、AKT1、MMP9 蛋白的表达以及p-PI3K/ PI3K、p-AKT1 / AKT1 的比值。综上,KR-GRR 药对可能通过抑制PI3K/ AKT1 / MMP9 信号通路激活来发挥治疗MA 的作用。

关键词:

"> 甘遂-甘草药对, 恶性腹水, 网络药理学, 分子对接, PI3K/ AKT1 / MMP9 信号通路

Abstract:

This study aims to explore the mechanism of Kansui Radix-Glycyrrhizae Radix et Rhizoma (KR-GRR) herb pair on malignant ascites (MA) by using network pharmacology and animal experiment. Firstly,the active components of KR-GRR herb pair and the corresponding targets were screened from the TCMSP database. The common targets and signaling pathways of KR-GRR herb pair in treating MA were predicted by network pharmacology,and a protein-protein interaction network was constructed to form a visualized map of Chinese Tradition medicine-components-diseases-targets. GO and KEGG analyses were used to predict the underlying mechanism of KR-GRR herb pair in treating MA. Secondly,molecular docking was employed to obtain the binding ability of the active components of KR-GRR herb pair to the core targets. Finally,the MA mice model was developed using H22 liver cancer cells for the mechanism validation. As a result,network pharmacology results indicated that 13 core bioactive components and 51 potential targets of KR-GRR against MA,with key targets including serine/ threonineprotein kinase 1 (AKT1),tumor necrosis factor (TNF),interleukin- 6 (IL-6),tumor protein 53 (TP53),IL-1β,and Matrix metallopeptidase 9 (MMP9). A total of 141 signaling pathways were screened out by KEGG analysis,and molecular docking results suggested that the PI3K/ AKT1 / MMP9 signaling pathway played a pivotal role in the therapeutic effects of KR-GRR against MA. The animal experiment demonstrated that KR-GRR herb pair significantly improved the general condition,survival rate,and peritoneal histopathological damage in MA mice. Additionally,2. 5 g/ kg of KR-GRR reduced abdominal circumference and ascites volume,and suppressed the expression of AKT1 and MMP9 in ascitic fluid. Furthermore,KR-GRR downregulated the mRNA levels of AKT1,TNF,IL-6,TP53,IL-1β,and MMP9 in peritoneal tissues,as well as the protein expression of p-PI3K,PI3K,p-AKT1,AKT1,and MMP9,especially the ratios of p-PI3K/ PI3K and p-AKT1 / AKT1. Taken together,KRGRR herb pair may exert therapeutic effects against MA by inhibiting the activation of the PI3K/ AKT1 / MMP9 signaling pathway.

Key words:

"> Kansui Radix-Glycyrrhizae Radix et Rhizoma herb pair, malignant ascites, network pharmacology, molecular docking, PI3K/ AKT1 / MMP9 signaling pathway

中图分类号: 

R285 ','1');return false;" target="_blank"> "> R285